IL141580A0 - Diagnostics based on tetrazolium compounds - Google Patents

Diagnostics based on tetrazolium compounds

Info

Publication number
IL141580A0
IL141580A0 IL14158001A IL14158001A IL141580A0 IL 141580 A0 IL141580 A0 IL 141580A0 IL 14158001 A IL14158001 A IL 14158001A IL 14158001 A IL14158001 A IL 14158001A IL 141580 A0 IL141580 A0 IL 141580A0
Authority
IL
Israel
Prior art keywords
diagnostics based
tetrazolium compounds
tetrazolium
compounds
diagnostics
Prior art date
Application number
IL14158001A
Other languages
English (en)
Original Assignee
Lifescan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifescan Inc filed Critical Lifescan Inc
Publication of IL141580A0 publication Critical patent/IL141580A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/525Multi-layer analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/64Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving ketones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/962Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/97Test strip or test slide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/17Nitrogen containing
    • Y10T436/173076Nitrite or nitrate

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Emergency Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
IL14158001A 2000-02-25 2001-02-21 Diagnostics based on tetrazolium compounds IL141580A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/513,071 US6656697B1 (en) 1998-09-28 2000-02-25 Diagnostics based on tetrazolium compounds

Publications (1)

Publication Number Publication Date
IL141580A0 true IL141580A0 (en) 2002-03-10

Family

ID=24041784

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14158001A IL141580A0 (en) 2000-02-25 2001-02-21 Diagnostics based on tetrazolium compounds

Country Status (22)

Country Link
US (3) US6656697B1 (xx)
EP (1) EP1130111B1 (xx)
JP (1) JP2001292795A (xx)
KR (1) KR20010085564A (xx)
CN (1) CN1214117C (xx)
AR (1) AR027544A1 (xx)
AT (1) ATE278804T1 (xx)
AU (1) AU782774B2 (xx)
BR (1) BR0102467A (xx)
CA (1) CA2337562A1 (xx)
DE (1) DE60106110T2 (xx)
DK (1) DK1130111T3 (xx)
ES (1) ES2230240T3 (xx)
HK (1) HK1038772A1 (xx)
IL (1) IL141580A0 (xx)
MX (1) MXPA01002062A (xx)
MY (1) MY134005A (xx)
NO (1) NO20010939L (xx)
PT (1) PT1130111E (xx)
RU (1) RU2269784C2 (xx)
SG (1) SG100621A1 (xx)
ZA (1) ZA200101543B (xx)

Families Citing this family (147)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US6656697B1 (en) * 1998-09-28 2003-12-02 Lifescan, Inc. Diagnostics based on tetrazolium compounds
US6420128B1 (en) * 2000-09-12 2002-07-16 Lifescan, Inc. Test strips for detecting the presence of a reduced cofactor in a sample and method for using the same
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US7041068B2 (en) 2001-06-12 2006-05-09 Pelikan Technologies, Inc. Sampling module device and method
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7316700B2 (en) 2001-06-12 2008-01-08 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
ES2357887T3 (es) 2001-06-12 2011-05-03 Pelikan Technologies Inc. Aparato para mejorar la tasa de éxito de obtención de sangre a partir de una punción capilar.
AU2002348683A1 (en) 2001-06-12 2002-12-23 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
ATE450209T1 (de) 2001-06-12 2009-12-15 Pelikan Technologies Inc Gerät und verfahren zur entnahme von blutproben
WO2002100460A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Electric lancet actuator
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US7344507B2 (en) 2002-04-19 2008-03-18 Pelikan Technologies, Inc. Method and apparatus for lancet actuation
EP1867732B1 (en) * 2001-09-14 2015-01-28 Bayer HealthCare LLC Reagents, methods and devices for detecting analytes
US7163616B2 (en) * 2001-09-14 2007-01-16 Bayer Corporation Reagents and methods for detecting analytes, and devices comprising reagents for detecting analytes
US6939685B2 (en) * 2001-11-20 2005-09-06 Lifescan, Inc. Stabilized tetrazolium phenazine reagent compositions and methods for using the same
US6586199B2 (en) * 2001-11-20 2003-07-01 Lifescan, Inc. Stabilized tetrazolium reagent compositions and methods for using the same
US6723500B2 (en) * 2001-12-05 2004-04-20 Lifescan, Inc. Test strips having reaction zones and channels defined by a thermally transferred hydrophobic barrier
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7198606B2 (en) 2002-04-19 2007-04-03 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with analyte sensing
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7892185B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7381539B2 (en) 2002-06-07 2008-06-03 Arkray, Inc. Method of assay by oxidation-reduction reaction with formazan
WO2003107011A1 (ja) * 2002-06-14 2003-12-24 アークレイ株式会社 スルホン酸化合物およびニトロ化合物を用いた測定方法
JP2007147630A (ja) * 2002-06-14 2007-06-14 Arkray Inc スルホン酸化合物およびニトロ化合物を用いた測定方法
US8021855B2 (en) 2002-07-17 2011-09-20 Arkray Inc. Method of decomposing protein with sulfonic acid compound
US8895298B2 (en) 2002-09-27 2014-11-25 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
DE602004028463D1 (de) 2003-05-30 2010-09-16 Pelikan Technologies Inc Verfahren und vorrichtung zur injektion von flüssigkeit
DK1633235T3 (da) 2003-06-06 2014-08-18 Sanofi Aventis Deutschland Apparat til udtagelse af legemsvæskeprøver og detektering af analyt
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US7220034B2 (en) * 2003-07-11 2007-05-22 Rudolph Technologies, Inc. Fiber optic darkfield ring light
EP1671096A4 (en) 2003-09-29 2009-09-16 Pelikan Technologies Inc METHOD AND APPARATUS FOR PROVIDING IMPROVED SAMPLE CAPTURING DEVICE
US9351680B2 (en) 2003-10-14 2016-05-31 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a variable user interface
EP1706026B1 (en) 2003-12-31 2017-03-01 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
US20050164330A1 (en) 2004-01-27 2005-07-28 Daiichi Pure Chemicals Co., Ltd. Method for quantitatively determining a specific component in a biological specimen, and reagent for quantitative determination
US20050282293A1 (en) * 2004-03-03 2005-12-22 Cosman Maury D System for delivering a diluted solution
US20060121624A1 (en) * 2004-03-03 2006-06-08 Huang Lotien R Methods and systems for fluid delivery
US7504693B2 (en) * 2004-04-23 2009-03-17 International Business Machines Corporation Dislocation free stressed channels in bulk silicon and SOI CMOS devices by gate stress engineering
EP1751546A2 (en) 2004-05-20 2007-02-14 Albatros Technologies GmbH & Co. KG Printable hydrogel for biosensors
WO2005120365A1 (en) 2004-06-03 2005-12-22 Pelikan Technologies, Inc. Method and apparatus for a fluid sampling device
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US20060002817A1 (en) * 2004-06-30 2006-01-05 Sebastian Bohm Flow modulation devices
US20060000710A1 (en) 2004-06-30 2006-01-05 Klaus Peter Weidenhaupt Fluid handling methods
WO2006013921A1 (ja) 2004-08-05 2006-02-09 Asahi Kasei Pharma Corporation プロテアーゼ反応促進剤及び/又は色素の安定化剤を含む試薬
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
US20060223178A1 (en) * 2005-04-05 2006-10-05 Tom Barber Devices and methods for magnetic enrichment of cells and other particles
US20070026418A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
EP1915618A4 (en) * 2005-06-02 2009-09-30 Fluidigm Corp ANALYSIS USING MICROFLUIDIC SEPARATION DEVICES
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070059680A1 (en) * 2005-09-15 2007-03-15 Ravi Kapur System for cell enrichment
US20090181421A1 (en) * 2005-07-29 2009-07-16 Ravi Kapur Diagnosis of fetal abnormalities using nucleated red blood cells
US20070059719A1 (en) * 2005-09-15 2007-03-15 Michael Grisham Business methods for prenatal Diagnosis
US20070059716A1 (en) * 2005-09-15 2007-03-15 Ulysses Balis Methods for detecting fetal abnormality
US20070059781A1 (en) * 2005-09-15 2007-03-15 Ravi Kapur System for size based separation and analysis
US20070059774A1 (en) * 2005-09-15 2007-03-15 Michael Grisham Kits for Prenatal Testing
US20080050739A1 (en) * 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
EP2029779A4 (en) * 2006-06-14 2010-01-20 Living Microsystems Inc HIGHLY PARALLEL SNP GENOTYPING UTILIZATION FOR FETAL DIAGNOSIS
EP2589668A1 (en) 2006-06-14 2013-05-08 Verinata Health, Inc Rare cell analysis using sample splitting and DNA tags
US8137912B2 (en) * 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
US20080090239A1 (en) * 2006-06-14 2008-04-17 Daniel Shoemaker Rare cell analysis using sample splitting and dna tags
US7591978B2 (en) 2006-08-10 2009-09-22 Inverness Medical Switzerland Gmbh Solid phase test device for sialidase assay
JP5017612B2 (ja) * 2006-09-15 2012-09-05 株式会社シノテスト 生体試料中の測定対象物質の測定方法及び測定試薬、ヘモグロビンの影響回避方法、並びにヘモグロビンの影響回避剤
JP4697809B2 (ja) 2007-02-22 2011-06-08 旭化成ファーマ株式会社 ロイコ色素の安定化方法
US8508620B2 (en) * 2007-02-24 2013-08-13 Nec Corporation Portable terminal capable of presenting images based on time
EP2178531A4 (en) * 2007-07-02 2012-01-11 Yu Ming METHODS AND COMPOSITIONS, TARGETS FOR COMBINED CANCER TREATMENTS
US8008068B2 (en) * 2008-02-29 2011-08-30 Light Pointe Medical, Inc. Nonhemolytic optical sensor with enhanced reflectance
US20090219509A1 (en) * 2008-02-29 2009-09-03 Hiroshi Nomura Optical sensor with enhanced reflectance
EP2265324B1 (en) 2008-04-11 2015-01-28 Sanofi-Aventis Deutschland GmbH Integrated analyte measurement system
EP2295969B1 (en) * 2008-07-04 2016-05-18 Sekisui Medical Co., Ltd. Method for enhancing sensitivity or method for avoiding influence of hemoglobin in immunological measurement
PT2562268T (pt) 2008-09-20 2017-03-29 Univ Leland Stanford Junior Diagnóstico não invasivo de aneuploidia fetal por sequenciação
WO2010085815A1 (en) * 2009-01-26 2010-07-29 Artemis Health, Inc. Methods and compositions for identifying a fetal cell
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
DE102009033008A1 (de) 2009-07-02 2011-01-05 Dst Diagnostische Systeme & Technologien Gmbh Neues PoC-Testsystem und Verfahren
US9408880B2 (en) 2013-12-20 2016-08-09 Katherine Rose Kovarik Method and system for prevention and treatment of allergic and inflammatory diseases
US9457077B2 (en) 2009-11-18 2016-10-04 Katherine Rose Kovarik Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases
US9585920B2 (en) 2011-02-04 2017-03-07 Katherine Rose Kovarik Method and system for treating cancer cachexia
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9034593B2 (en) 2010-11-22 2015-05-19 Kimberly-Clark Worldwide, Inc. Vaginal indicator to detect biomarkers of good health
US10842834B2 (en) 2016-01-06 2020-11-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US10687975B2 (en) 2011-02-04 2020-06-23 Joseph E. Kovarik Method and system to facilitate the growth of desired bacteria in a human's mouth
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US11191665B2 (en) 2011-02-04 2021-12-07 Joseph E. Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US11523934B2 (en) 2011-02-04 2022-12-13 Seed Health, Inc. Method and system to facilitate the growth of desired bacteria in a human's mouth
US9730967B2 (en) 2011-02-04 2017-08-15 Katherine Rose Kovarik Method and system for treating cancer cachexia
US9987224B2 (en) 2011-02-04 2018-06-05 Joseph E. Kovarik Method and system for preventing migraine headaches, cluster headaches and dizziness
US10010568B2 (en) 2011-02-04 2018-07-03 Katherine Rose Kovarik Method and system for reducing the likelihood of a spirochetes infection in a human being
US11357722B2 (en) 2011-02-04 2022-06-14 Seed Health, Inc. Method and system for preventing sore throat in humans
US10548761B2 (en) 2011-02-04 2020-02-04 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US10086018B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US10245288B2 (en) 2011-02-04 2019-04-02 Joseph E. Kovarik Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
US10085938B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for preventing sore throat in humans
US10512661B2 (en) 2011-02-04 2019-12-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US10111913B2 (en) 2011-02-04 2018-10-30 Joseph E. Kovarik Method of reducing the likelihood of skin cancer in an individual human being
US11273187B2 (en) 2015-11-30 2022-03-15 Joseph E. Kovarik Method and system for reducing the likelihood of developing depression in an individual
US10835560B2 (en) 2013-12-20 2020-11-17 Joseph E. Kovarik Reducing the likelihood of skin cancer in an individual human being
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US10314865B2 (en) 2011-02-04 2019-06-11 Katherine Rose Kovarik Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
US11419903B2 (en) 2015-11-30 2022-08-23 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US10583033B2 (en) 2011-02-04 2020-03-10 Katherine Rose Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
EP2852682B1 (en) 2012-05-21 2017-10-04 Fluidigm Corporation Single-particle analysis of particle populations
US8877023B2 (en) * 2012-06-21 2014-11-04 Lifescan Scotland Limited Electrochemical-based analytical test strip with intersecting sample-receiving chambers
BR112014028616B1 (pt) 2012-06-22 2020-12-29 F. Hoffmann-La Roche Ag método para a detecção de pelo menos um analito em pelo menos uma amostra de um fluido do corpo, dispositivo e sistema de teste
JP6299984B2 (ja) * 2013-04-26 2018-03-28 三菱瓦斯化学株式会社 黄色系還元型ピロロキノリンキノン結晶及びその製造方法、並びに、食品、医薬品、ゲル、組成物及び組成物の製造方法
WO2015069872A2 (en) * 2013-11-08 2015-05-14 The Board Of Trustees Of The University Of Illinois Personal glucose meters for detection and quantification of enzymes and metabolites based on coenzyme detection
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
EP3172570A4 (en) 2014-07-25 2017-12-27 Becton, Dickinson and Company Analyte test strip assays, and test strips and kits for use in practicing the same
US20180113127A1 (en) * 2015-02-25 2018-04-26 Sekisui Medical Co., Ltd. Immunoassay method and assay reagent used in said method
US9885663B2 (en) * 2015-10-25 2018-02-06 Adriel Sumathipala Portable, rapid, and inexpensive diagnostic tests for cardiac disease risk
EA201800291A1 (ru) * 2016-05-26 2018-09-28 Общество С Ограниченной Ответственностью Научно-Производственное Предприятие "Биочип" Биочип для мультиплексного анализа и способ исследования клеток при диагностике онкологических заболеваний
WO2019089768A1 (en) * 2017-11-01 2019-05-09 William Marsh Rice University Low resource device and system for measurement of bilirubin levels
CN108359710B (zh) * 2018-02-11 2019-04-30 山东大学齐鲁医院 葡萄糖磷酸异构酶的酶显色定量测定试剂盒及测定方法
CN112557663A (zh) * 2019-09-25 2021-03-26 百略医学科技股份有限公司 检测条及检测条的制造方法
WO2023112442A1 (ja) * 2021-12-13 2023-06-22 テルモ株式会社 生体成分濃度測定試薬、測定方法およびセンサ

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE411464C (de) 1923-03-24 1925-03-30 Christian Reitzammer Gefaess mit am Boden angebrachter, einen Elektrodenheizkoerper aufnehmender Kapsel
US3694974A (en) * 1970-03-10 1972-10-03 Alan Eckel Audiometric survey booth
US3791988A (en) 1972-03-23 1974-02-12 Hoffmann La Roche Diagnostic test for glucose
CS164231B2 (xx) 1972-09-28 1975-11-07
FR2258235B1 (xx) 1974-01-21 1981-02-06 Voest Ag
US4254222A (en) * 1978-07-19 1981-03-03 Owen Oliver E Semi-quantitative assay of lactic acid and β-hydroxy butyrate
US4368243A (en) 1980-10-10 1983-01-11 W. R. Grace & Co. Battery separator
DE3048662A1 (de) 1980-12-23 1982-07-22 Boehringer Mannheim Gmbh, 6800 Mannheim Stabilisierte zubereitung von tetrazoliumsalzen
US4366243A (en) * 1981-04-17 1982-12-28 Miles Laboratories, Inc. Stabilization of glucose oxidase apoenzyme
JPS5818167A (ja) * 1981-07-24 1983-02-02 Fuji Photo Film Co Ltd 分析フイルム及びこれを用いる分析方法
US4461829A (en) * 1981-09-14 1984-07-24 Miles Laboratories, Inc. Homogeneous specific binding assay element and lyophilization production method
JPS58129994A (ja) 1982-01-27 1983-08-03 Toyo Jozo Co Ltd 高感度測定法
DE3247894A1 (de) 1982-12-24 1984-06-28 Merck Patent Gmbh, 6100 Darmstadt Testsystem und verfahren zur bestimmung von nad(p)h
JPS59162899A (ja) 1983-03-08 1984-09-13 Kyoto Daiichi Kagaku:Kk β‐ヒドロキシ酪酸の定量用組成物
JPS6024199A (ja) 1983-07-18 1985-02-06 Nippon Chemiphar Co Ltd 疾病関連物質の定量法
JPS60180600A (ja) 1984-02-29 1985-09-14 Kyowa Medetsukusu Kk 還元型ニコチンアミド・アデニン・ジヌクレオチドの定量方法
JPS60251895A (ja) 1984-05-29 1985-12-12 Ube Ind Ltd ピロロキノリンキノンの製造方法
JPH0672883B2 (ja) * 1985-06-19 1994-09-14 コニカ株式会社 分析素子
US4937047A (en) 1986-04-01 1990-06-26 Konishiroku Photo Industry Co., Ltd. Analytical element
US4935346A (en) * 1986-08-13 1990-06-19 Lifescan, Inc. Minimum procedure system for the determination of analytes
US5178831A (en) * 1986-10-08 1993-01-12 Dai Nippon Insatsu Kab Ushiki Kaisha Device for testing body fluids
US5036000A (en) 1986-12-16 1991-07-30 Enzymatics, Inc. Threshold color control system
US5126247A (en) 1988-02-26 1992-06-30 Enzymatics, Inc. Method, system and devices for the assay and detection of biochemical molecules
US5196519A (en) * 1988-07-05 1993-03-23 Eastman Kodak Company Reducible compounds which provide aniline dyes, and analytical compositions, elements and methods using same
DE3826922A1 (de) 1988-08-09 1990-02-22 Boehringer Mannheim Gmbh Verfahren zur kolorimetrischen bestimmung eines analyten mittels enzymatischer oxidation
US5340722A (en) 1988-08-24 1994-08-23 Avl Medical Instruments Ag Method for the determination of the concentration of an enzyme substrate and a sensor for carrying out the method
SE466158B (sv) 1989-04-25 1992-01-07 Migrata Uk Ltd Analysmetod foer glukosbestaemning i helblod
EP0400918A1 (en) 1989-05-31 1990-12-05 Nakano Vinegar Co., Ltd. Enzyme sensor
US5166051A (en) * 1990-08-08 1992-11-24 Genesis Labs, Inc. Membranes, membrane overlays for exclusion of erythrocytes, and method for immunoassay of whole blood analytes
US5126275A (en) 1990-09-19 1992-06-30 Miles Inc. Analytical method using tetrazolium salt indicators having a reflectance plateau
DE4041569A1 (de) * 1990-12-22 1992-06-25 Hoechst Ag Verfahren zur aufarbeitung schwefelwasserstoff, cyanwasserstoff und ammoniak enthaltender waessriger loesungen
EP0654079B1 (en) * 1992-07-02 2000-03-22 Roche Diagnostics Corporation A reagent stabilized by bivalent metal salts
EP0648278B1 (en) 1992-07-02 1999-12-08 Roche Diagnostics Corporation Stabilizing tetrazolium salts in a reagent
US5510245A (en) 1992-09-08 1996-04-23 Bayer Corporation Composition and method of assaying for ketone bodies
US5298144A (en) 1992-09-15 1994-03-29 The Yellow Springs Instrument Company, Inc. Chemically wired fructose dehydrogenase electrodes
DE4311464A1 (de) 1993-04-08 1994-10-13 Boehringer Mannheim Gmbh Verfahren zur kolorimetrischen Bestimmung eines Analyten mit einer PQQ-abhängigen Dehydrogenase
CA2127172C (en) 1993-08-05 1998-07-14 Amy H. Chu Analyte detection device and process
US5360595A (en) 1993-08-19 1994-11-01 Miles Inc. Preparation of diagnostic test strips containing tetrazolium salt indicators
US5563031A (en) * 1994-09-08 1996-10-08 Lifescan, Inc. Highly stable oxidative coupling dye for spectrophotometric determination of analytes
JP2757348B2 (ja) 1996-04-18 1998-05-25 株式会社同仁化学研究所 新規水溶性テトラゾリウム塩化合物
US6040195A (en) * 1997-06-10 2000-03-21 Home Diagnostics, Inc. Diagnostic sanitary test strip
US5948695A (en) * 1997-06-17 1999-09-07 Mercury Diagnostics, Inc. Device for determination of an analyte in a body fluid
AU2005399A (en) * 1997-12-19 1999-07-12 Amira Medical Embossed test strip system
US6656697B1 (en) * 1998-09-28 2003-12-02 Lifescan, Inc. Diagnostics based on tetrazolium compounds
US5902731A (en) 1998-09-28 1999-05-11 Lifescan, Inc. Diagnostics based on tetrazolium compounds
US6420128B1 (en) * 2000-09-12 2002-07-16 Lifescan, Inc. Test strips for detecting the presence of a reduced cofactor in a sample and method for using the same

Also Published As

Publication number Publication date
EP1130111A3 (en) 2002-07-03
AR027544A1 (es) 2003-04-02
CN1317575A (zh) 2001-10-17
EP1130111B1 (en) 2004-10-06
US20040053352A1 (en) 2004-03-18
AU782774B2 (en) 2005-08-25
MY134005A (en) 2007-11-30
NO20010939D0 (no) 2001-02-23
PT1130111E (pt) 2005-01-31
ES2230240T3 (es) 2005-05-01
DK1130111T3 (da) 2005-02-28
SG100621A1 (en) 2003-12-26
RU2269784C2 (ru) 2006-02-10
JP2001292795A (ja) 2001-10-23
ZA200101543B (en) 2002-08-23
US6656697B1 (en) 2003-12-02
MXPA01002062A (es) 2002-08-20
AU2321001A (en) 2001-08-30
HK1038772A1 (en) 2002-03-28
NO20010939L (no) 2001-08-27
CN1214117C (zh) 2005-08-10
DE60106110T2 (de) 2006-03-09
KR20010085564A (ko) 2001-09-07
EP1130111A2 (en) 2001-09-05
DE60106110D1 (de) 2004-11-11
BR0102467A (pt) 2001-12-04
CA2337562A1 (en) 2001-08-25
US20050112712A1 (en) 2005-05-26
US7144709B2 (en) 2006-12-05
ATE278804T1 (de) 2004-10-15
US7011954B2 (en) 2006-03-14

Similar Documents

Publication Publication Date Title
SG100621A1 (en) Diagnostics based on tetrazolium compounds
IL129594A0 (en) Diagnostics based on tetrazolium compounds
EP1288663A4 (en) EXTRASOMATIC DIAGNOSTICS
GB0016690D0 (en) Eplthelial diagnostic aid
HU0402189D0 (en) Intermediate compounds
TW461397U (en) Gear case
GB0003637D0 (en) Compounds
GB0014642D0 (en) Compounds
GB0015863D0 (en) Compounds
GB0018351D0 (en) Compounds
GB0015852D0 (en) Compounds
GB0005574D0 (en) Compounds
GB0014823D0 (en) Compounds
GB0005370D0 (en) Compounds
GB0004053D0 (en) Compounds
GB0014652D0 (en) Compounds
GB0015853D0 (en) Compounds
GB0014641D0 (en) Compounds
GB0003633D0 (en) Compounds
GB0003631D0 (en) Compounds
GB0003609D0 (en) Compounds
GB0009457D0 (en) Compounds
GB0003608D0 (en) Compounds
GB0003600D0 (en) Compounds
GB0003599D0 (en) Compounds